Dolutegravir-Lamivudine as initial therapy in HIV-Infected, ARV naïve patients 48 Week Results of the PADDLE trial.

Conference Reports for NATAP

International AIDS Conference
Durban, South Africa
July 18-22 2016


Dolutegravir-Lamivudine as initial therapy in HIV-Infected, ARV naïve patients 48 Week Results of the PADDLE trial.

	Reported by Jules Levin Durban 2016 July 18-22 Pedro Cahn, Maria J Rolón, María I. Figueroa, Ana Gun, Patricia Patterson, Omar Sued